A supramolecule that inhibits the colony stimulating factor 1 and SIRPα receptors on macrophages significantly enhances antitumour and antimetastatic efficacies in two aggressive animal models of melanoma and breast cancer.
- Ashish Kulkarni
- Vineethkrishna Chandrasekar
- Shiladitya Sengupta